formaldehyde has been researched along with transforming growth factor alpha in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bermudez, E; Gross, EA; Lyght, O; Morgan, KT; Recio, L; Wolf, DC | 1 |
| Akkoyunlu, G; Demir, R; Ustünel, I | 1 |
| Izumi, N; Joko, K; Nishijima, N; Nishio, K; Orito, E; Osaki, Y; Sakai, K; Takeda, H; Uchida, Y | 1 |
3 other study(ies) available for formaldehyde and transforming growth factor alpha
| Article | Year |
|---|---|
Immunohistochemical localization of p53, PCNA, and TGF-alpha proteins in formaldehyde-induced rat nasal squamous cell carcinomas.
Topics: Animals; Carcinoma, Squamous Cell; Formaldehyde; Immunoenzyme Techniques; Male; Nose Neoplasms; Proliferating Cell Nuclear Antigen; Rats; Rats, Inbred F344; Transforming Growth Factor alpha; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1995 |
Distribution patterns of TGF-alpha, laminin and fibronectin and their relationship with folliculogenesis in rat ovary.
Topics: Animals; Cell Nucleus; Female; Fibronectins; Formaldehyde; Granulosa Cells; Immunohistochemistry; Laminin; Oocytes; Ovary; Rats; Tissue Distribution; Transforming Growth Factor alpha | 2003 |
Targeted DNA and RNA sequencing of fine-needle biopsy FFPE specimens in patients with unresectable hepatocellular carcinoma treated with sorafenib.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; beta Catenin; Biomarkers; Biomarkers, Tumor; Biopsy, Fine-Needle; Carcinoma, Hepatocellular; Female; Formaldehyde; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; High-Throughput Nucleotide Sequencing; Humans; Liver Neoplasms; Male; Middle Aged; Mutation; Neuregulin-1; Niacinamide; Paraffin Embedding; Phenylurea Compounds; Platelet Endothelial Cell Adhesion Molecule-1; Sequence Analysis, DNA; Sequence Analysis, RNA; Sorafenib; Transforming Growth Factor alpha; Treatment Outcome; Tumor Suppressor Protein p53 | 2015 |